Measles Outbreak Cases Cross 100 Mark In US, Australia Sees Sudden Surge Of The Infectious Disease

Updated Feb 23, 2025 | 11:46 AM IST

SummaryMeasles continues to create havoc with over 100 people infected in US. New health guidelines and advisories are being issued to ensure people remain safe and vigilant.
(Credit-Canva)

(Credit-Canva)

The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

End of Article

CDSCO Launches National Crackdown On Unapproved Medicines

Updated Mar 26, 2026 | 06:03 PM IST

SummaryThe Central Drugs Standard Control Organisation (CDSCO) has now launched a nationwide crackdown on unapproved Fixed Dose Combination (FDCs) after 90 combination medicines that were being sold without mandatory central approval were busted last week
CDSCO Launches National Crackdown On Unapproved Medicines

Credit: Canva, CDSCO

The Central Drugs Standard Control Organisation (CDSCO) has now launched a nationwide crackdown on unapproved Fixed Dose Combination (FDCs) after 90 combination medicines that were being sold without mandatory central approval were busted last week.

CDSCO, India's apex drug regulatory body in the country, made the shocking discovery after scrutinizing drug samples uploaded on the SUGAM portal, the government’s online system for drug testing data.

Several of these samples were found to fall under the ‘new drug’ category but lacked approval from the central authority. As a result, the CDSCO wrote a letter to all states and union territory drug controllers, asking them to investigate manufacturers and marketers of these FDCs.

The letter reads: "The SUGAM lab testing data for the year 2025, a large number of drug samples (FDCs) are detected as unapproved and fall under the category of 'New Drug'. No new drug shall be manufactured for sale unless it is approved by the Licensing Authority 'as defined in Rule 3 of New Drugs and Clinical Trial Rules, 2019, Further, as per Rule 80 of New Drugs & Clinical Trial Rules 2019, a person who intends to manufacture new drug in the form of API or Pharmaceuticals formulation, as the case may be, for sale or distribution, shall make an application for grant of permission to the Central Licensing Authority in Form CT-21 along with a fee as specified in Sixth Schedule."

"The presence of unapproved drugs in the supply chain is a matter of serious concern, posing potential risks to public health and safety. It also indicates non- compliance with the provisions of the Drugs and Cosmetics Act, 1940, and rules made thereunder.

"Accordingly, please initiate appropriate investigation and regulatory action against the concerned manufacturers, marketers, and other stakeholders, as deemed fit. Kindly ensure strict monitoring and enforcement to prevent manufacture, sale, and distribution of such unapproved drugs," the letter states, on appropriate action against the sale and distribution of unapproved drugs.

FDCs are drugs that contain two or more active ingredients in a single formulation. The CDSCO has asked states to investigate and submit reports on the action taken at the earliest.

What Made It To The Unapproved List Of FDCs?

Cough And Cold Medicines

Cough and cold combination medicines have formed the single largest group. At least 14 to 16 entries show combination of ingredients found in everyday pharmacy shelves: dextromethorphan, ambroxol, guaiphenesin, chlorpheniramine, phenylephrine, terbutaline, and menthol in various permutations.

Several of these are sold as flavoured syrups for children. Budesonide-levosalbutamol inhalation suspension that is used for asthma and chronic obstructive pulmonary disease, too features in the list.

Nutritional Supplements

The next group is of the vitamins, minerals and other nutritional supplement which has roughly 18 to 20 entries. They include:

  • Multivitamin capsules
  • Iron-folic acid syrups
  • Calcium-vitamin D3-K2 combinations
  • Abapentin-methylcobalamin preparation
Antifungal And Dermatological Combinations

This group has accounted for at least 10 entries, which include antifungal creams that could lead to potential misuse and skin damage when sold without prescriptions.

Anti-Diabetic Medicines

This has accounted for six entries, and the combination includes:

  • Glimepiride paired with metformin or pioglitazone

What Is India's Rule For FDCs?

Under India's New Drugs and Clinical Trial Rules of 2019, any FDC is treated as a new drug and must have the central government's approval before it could be manufactured and sold. The regulator's letter noted that there were presence of unapproved drugs in the supply chain that could pose risks to public health. This also amounts to a violation of the Drugs and Cosmetics Act, 1940.

“The presence of unapproved drugs in the supply chain is a matter of serious concern, posing potential risks to public health and safety. It also indicates non- compliance with the provisions of the Drugs and Cosmetics Act, 1940, and Rules made thereunder," it said.

DCGI urged states and UTs "to examine the unapproved FDCs in generic name as mentioned in the attached annexure". This is done to check whether any approval has been granted by the local office. "Accordingly, please initiate appropriate investigation and regulatory action against the concerned manufacturers, marketers, and other stakeholders, as deemed fit. Kindly ensure strict monitoring and enforcement to prevent the manufacture, sale, and distribution of such unapproved drugs," the letter noted.

End of Article

‘Breakbone Fever’: US CDC Warns Of Dengue Surge Across 17 Countries

Updated Mar 26, 2026 | 07:00 PM IST

SummaryThe CDC stated a higher-than-expected number of cases and urged people planning to travel to countries with an uptick in cases to be aware of the risk. ​In 2026, the US reported a total of 496 dengue cases to date, a majority among travelers.
‘Breakbone Fever’: US CDC Warns Of Dengue Surge Across 17 Countries

Credit: Canva

Breakbone Fever, also known as dengue, is a mosquito-borne disease that is once again on the rise, with the U.S. Centers for Disease Control and Prevention issuing a travel alert across 17 Countries.

The federal agency flagged 'Level 1' risk for breakbone fever, calling for practicing usual precautions. It stated a higher-than-expected number of cases and urged people planning to travel to countries with an uptick in cases to be aware of the risk.

The CDC alert issued on March 23 identified 17 countries reporting an increased number of cases of dengue. These include: Afghanistan, Bangladesh, Bolivia, Colombia, Cook Islands, Cuba, Guyana, Maldives, Mali, Mauritania, New Caledonia, Pakistan, Samoa, Sudan, Timor-Leste, Vietnam, and the United States territories of American Samoa, Puerto Rico, and the US Virgin Islands, where local transmission is already common.

In 2026, the US reported a total of 496 dengue cases to date, and the vast majority of these cases were reported among people who contracted the illness while traveling abroad.

The CDC advised travelers to risk areas to prevent mosquito bites by

  • using an EPA-registered insect repellent,
  • wearing long-sleeved shirts
  • long pants when outdoors,
  • sleeping in an air-conditioned room or a room with window screens.
Also read: Long-term Exposure To Air Pollution Increases Fatality Rates In Dengue: Study

What Is Dengue? Why Is It Called Breakbone Fever

Dengue is a disease caused by a virus spread through mosquito bites. It is transmitted through infected mosquitoes, primarily the species Aedes aegypti.

The breakbone fever is caused by an infection with any of four different dengue viruses. These include:

  • Dengue virus type 1 (DENV-1 or DEN-1)
  • Dengue virus type 2 (DENV-2 or DEN-2)
  • Dengue virus type 3 (DENV-3 or DEN-3)
  • Dengue virus type 4 (DENV-4 or DEN-4)

Common Symptoms of the dengue are:

  • Sudden onset of high-grade fever.
  • Intense headache
  • Severe muscle, joint, or bone pain.
  • Skin Rash that often appears 2–5 days after the fever starts
  • Nausea and Vomiting
  • Minor bleeding
  • Fatigue.
Dengue is also referred to as “breakbone fever” because, along with high fever, it causes severe aches and pains, especially in the legs, joints, and back.

The disease can take up to 2 weeks to develop, with illness generally lasting less than a week.

However, it can quickly become severe within a few hours, usually requiring hospitalization.

In severe cases, health effects can include hemorrhage (uncontrolled bleeding), shock (seriously low blood pressure), organ failure, and death.

Breakbone Fever: Global Burden

According to the World Health Organization (WHO), about half of the world's population is now at risk of dengue.

It estimates that:

  • About 390 million dengue infections occur annually worldwide
  • Nearly 100 million people develop symptoms each year
Around 1 out of every 20 people infected by the dengue virus also develops severe dengue, a life-threatening medical emergency that requires immediate medical attention.

The two main authorized vaccines in the world against dengue are Dengvaxia and Qdenga.

These vaccines are designed to protect against all four serotypes of the virus, with a focus on reducing severe disease and hospitalizations.

In addition, the Butantan-DV vaccine developed by the Butantan Institute in São Paulo has shown potential to be over 80 percent effective in preventing the risk of severe disease for up to five years. It also offers broader protection against all four dengue serotypes.

End of Article

Sonia Gandhi Under Treatment for Systemic Infection, Responding Well: Doctors

Updated Mar 26, 2026 | 05:17 PM IST

SummaryThe Rajya Sabha MP was admitted to the Sir Ganga Ram Hospital with mild illness and is stable. The hospital stated that she is undergoing antibiotic treatment for systemic infection, and is responding well.
Sonia Gandhi Under Treatment for Systemic Infection, Responding Well: Doctors

Credit: SoniaGandhi/X

Sonia Gandhi, Congress Parliamentary Party chairperson, is under treatment for systemic infection, said the doctors treating her at the private hospital in Delhi, today.

The Rajya Sabha MP was admitted to the Sir Ganga Ram Hospital on March 24, 2026. As per initial reports, she was feeling unwell due to the change in weather and has been put under observation.

"Sonia Gandhi has been admitted to Sir Ganga Ram Hospital on 24th March night for fever. As per Dr. Ajay Swaroop, Chairman of SGRH, she is undergoing treatment with antibiotics for systemic infection,” the hospital said in a statement.

She "is showing response to treatment", it added.

Earlier, the hospital noted that the doctors are conducting further investigations to check for possible infection in the stomach and urinary tract.

What Is A Systemic Infection?

Systemic infection occurs in the bloodstream and affects the entire body, rather than a single organ or body part.

It occurs when pathogens like bacteria, viruses, or fungi enter the bloodstream and travel to multiple organs and tissues.

These infections can be life-threatening and common symptoms include:

  • high fever,
  • fatigue,
  • rapid heart rate,
  • confusion.
They often require rapid, comprehensive medical treatment, such as systemic antibiotics or antivirals.

Earlier this year, in January, Sonia Gandhi was admitted to Sir Ganga Ram Hospital after she suffered respiratory discomfort.

Also Read: COVID Variant BA.3.2 Spreads To 23 Countries: Is The Variant Under Monitoring A Cause Of Worry?

Did Delhi Pollution Make Sonia Gandhi Sick?

Due to an increase in population during the peak winter season in Delhi, the 79-year-old Parliamentarian had been regular with hospital visits and check-ups. Hospital source, while speaking to the news agency PTI, said that "it is a routine admission".

According to reports, she had complained of some respiratory discomfort. Once her medical examination was done, it was found that "her bronchial asthma had been mildly exacerbated", confirmed Dr. Swaroop.

A hospital source told PTI that this is due to the combined effects of cold weather and pollution.

As a precautionary measure, she was admitted to the hospital for further observation and treatment. The physicians who were treating her made a decision on her discharge based on her clinical progress.

Sonia Gandhi's Health History

On June 7, 2025, she was admitted to the Indira Gandhi Medical College and Hospital (IGMC) in Shimla for a routine medical check-up. She was also later discharged after her medical examination.

As per Naresh Chauhan, Principal Advisor (Media) to the Himachal Pradesh Chief Minister, she was brought in due to minor health concerns. However, he said that after being put under observation by doctors to assess her condition, she was stable.

Dr. Aman Chauhan, Deputy Medical Superintendent at IGMC, said, "Her blood pressure was slightly on the higher side, but there is nothing serious. No additional tests were conducted; only routine investigations were carried out. She was not given any special medical advice because everything was perfectly fine."

In the same month, on June 15, she was admitted to Sir Ganga Ram Hospital again under the Department of Surgical Gastroenterology for a stomach-related issue. Before that, she was again in the Delhi hospital on June 9 for a medical check-up.

End of Article